Biotricity CEO speaks to the future of AI and its contributions to healthcare
May 23, 2023
REDWOOD CITY, Calif., May 23, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology…
Biotricity Reaches $13M Revenue Run Rate in April 2023 on Accelerating Growth
May 16, 2023
REDWOOD CITY, Calif., May 16, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology…
Biotricity’s founder & CEO Waqaas Al-Siddiq to present at World Heart Summit May 19-21 in Geneva, Switzerland
May 10, 2023
REDWOOD CITY, Calif., May 10, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology…
Biotricity reaches $12M revenue run rate in March with promising future growth ahead
April 19, 2023
REDWOOD CITY, Calif., Apr 19, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), leading medical diagnostic and consumer healthcare technology…
Leading medical biometric firm Biotricity releases first corporate impact report
April 11, 2023
REDWOOD CITY, Calif., Apr 11, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology…
Medical biometric firm Biotricity reshaping market through pioneering innovation
March 7, 2023
REDWOOD CITY, Calif., Mar 07, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity reports financial results for Fiscal 2023 Third Quarter
February 14, 2023
REDWOOD CITY, Calif., Feb 14, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity To host Fiscal 2023 Third Quarter Financial Results call on February 14th at 4:30pm ET
February 9, 2023
REDWOOD CITY, Calif., Feb 09, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity selected to present its work on AI enabled stroke prediction in CKD patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference
February 3, 2023
REDWOOD CITY, Calif., Feb 03, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity signs distribution agreement with top 5 distributor for its Cardiac Monitoring Solutions
January 26, 2023
REDWOOD CITY, Calif., Jan 26, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity to participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET
January 25, 2023
REDWOOD CITY, Calif., Jan 23, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity signs with top 5 group purchasing organization; potential for higher sales volume in 2023
January 17, 2023
REDWOOD CITY, Calif., Jan 17, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…